Cassava Sciences, Inc. PX91.F Stock
Cassava Sciences, Inc. Price Chart
Cassava Sciences, Inc. PX91.F Financial and Trading Overview
| Cassava Sciences, Inc. stock price | 19.96 EUR |
| Previous Close | 23.5 EUR |
| Open | 23.29 EUR |
| Bid | 22.77 EUR x 0 |
| Ask | 22.98 EUR x 0 |
| Day's Range | 22.85 - 23.29 EUR |
| 52 Week Range | 13.48 - 54.6 EUR |
| Volume | 300 EUR |
| Avg. Volume | 20 EUR |
| Market Cap | 953.97M EUR |
| Beta (5Y Monthly) | -0.137676 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.99 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 159.25 EUR |
PX91.F Valuation Measures
| Enterprise Value | 793.64M EUR |
| Trailing P/E | N/A |
| Forward P/E | -51.93182 |
| PEG Ratio (5 yr expected) | -1.1 |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 4.676627 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -9.088 |
Trading Information
Cassava Sciences, Inc. Stock Price History
| Beta (5Y Monthly) | -0.137676 |
| 52-Week Change | -4.93% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 54.6 EUR |
| 52 Week Low | 13.48 EUR |
| 50-Day Moving Average | 21.91 EUR |
| 200-Day Moving Average | 28.95 EUR |
PX91.F Share Statistics
| Avg. Volume (3 month) | 20 EUR |
| Avg. Daily Volume (10-Days) | 19 EUR |
| Shares Outstanding | 41.75M |
| Float | 39.28M |
| Short Ratio | N/A |
| % Held by Insiders | 6.00% |
| % Held by Institutions | 27.18% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:7 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -23.98% |
| Return on Equity (ttm) | -37.62% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -68032000 EUR |
| EBITDA | -87332000 EUR |
| Net Income Avi to Common (ttm) | -82990000 EUR |
| Diluted EPS (ttm) | -1.98 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 187.47M EUR |
| Total Cash Per Share (mrq) | 4.49 EUR |
| Total Debt (mrq) | 0 EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 14.02 |
| Book Value Per Share (mrq) | 4.886 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -67239000 EUR |
| Levered Free Cash Flow (ttm) | -42271376 EUR |
Profile of Cassava Sciences, Inc.
| Country | Germany |
| State | TX |
| City | Austin |
| Address | 6801 N. Capital of Texas Hwy, Bldg 1 |
| ZIP | 78731 |
| Phone | 512 501 2444 |
| Website | https://www.cassavasciences.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 26 |
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. The company was incorporated in 1998 and is based in Austin, Texas.
Q&A For Cassava Sciences, Inc. Stock
What is a current PX91.F stock price?
Cassava Sciences, Inc. PX91.F stock price today per share is 19.96 EUR.
How to purchase Cassava Sciences, Inc. stock?
You can buy PX91.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Cassava Sciences, Inc.?
The stock symbol or ticker of Cassava Sciences, Inc. is PX91.F.
Which industry does the Cassava Sciences, Inc. company belong to?
The Cassava Sciences, Inc. industry is Biotechnology.
How many shares does Cassava Sciences, Inc. have in circulation?
The max supply of Cassava Sciences, Inc. shares is 47.98M.
What is Cassava Sciences, Inc. Price to Earnings Ratio (PE Ratio)?
Cassava Sciences, Inc. PE Ratio is now.
What was Cassava Sciences, Inc. earnings per share over the trailing 12 months (TTM)?
Cassava Sciences, Inc. EPS is -1.99 EUR over the trailing 12 months.
Which sector does the Cassava Sciences, Inc. company belong to?
The Cassava Sciences, Inc. sector is Healthcare.